• 1. China National Health Development Research Center, Beijing 100191, P.R.China;
  • 2. Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, P.R.China;
  • 3. Health Insurance Administration Bureau of Hubei Province, Wuhan 430070, P.R.China;
  • 4. Medical Service Department, National Cancer Center; National Clinical Research Center for Cancer; Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100191, P.R.China;
  • 5. National Center for Drug and Technology Assessment, Beijing 100191, P.R.China;
YIN Shiquan, Email: yinshiquan@tsinghua.org.cn; LIU Yuehua, Email: liu_yuehua@163.com
Export PDF Favorites Scan Get Citation

Survival prognosis in patients with terminal cancer plays an important role in clinical decision-making, policy formulation, and end-stage patient with relatives. To date, foreign researchers have developed multiple survival prediction models based on patient clinical performance, biomarkers and other indicators, along with a large number of studies which have been externally verified, including Palliative Performance Scale (PPS), Palliative Prognostic Score (PaP), Delirium-Palliative Prognostic Score (D-PaP), and Palliative Prognostic Index (PPI), etc. China's research on this topic remains in the primary stage. Therefore, this article reviews the prognostic factors of terminal cancer and survival prediction models as well as applications, in order to provide references for the subsequent construction of survival prediction models for patients with terminal cancer in line with Chinese characteristics.

Citation: YANG Junting, DAI Wei, YIN Shiquan, LIU Yuehua. Advance and the status quo of the research on applications of prognostic tools in patients with advanced cancer. Chinese Journal of Evidence-Based Medicine, 2021, 21(1): 8-14. doi: 10.7507/1672-2531.202004004 Copy

  • Previous Article

    The methodological and reporting quality of protocols of systematic review on animal experiments: an analysis from PROSPERO platform
  • Next Article

    The citation status of systematic reviews/meta-analyses in clinical practice guidelines and consensuses of traditional Chinese medicine